MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $282,342 | -29.2% | 218,870 | -27.5% | 0.00% | – |
| Q2 2023 | $398,508 | +637.6% | 301,900 | +295.7% | 0.00% | – |
| Q1 2023 | $54,031 | +449.9% | 76,289 | +482.4% | 0.00% | – |
| Q4 2022 | $9,825 | -93.9% | 13,100 | -93.0% | 0.00% | – |
| Q3 2022 | $161,000 | -27.1% | 186,625 | -5.4% | 0.00% | – |
| Q2 2022 | $221,000 | +325.0% | 197,179 | +326.8% | 0.00% | – |
| Q1 2022 | $52,000 | -82.3% | 46,200 | -74.8% | 0.00% | – |
| Q4 2021 | $294,000 | -27.4% | 183,274 | +9.5% | 0.00% | – |
| Q3 2021 | $405,000 | -13.8% | 167,382 | +12.9% | 0.00% | – |
| Q2 2021 | $470,000 | -28.6% | 148,229 | -24.0% | 0.00% | – |
| Q1 2021 | $658,000 | – | 195,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |